Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-03-02 @ 4:26 AM
Study NCT ID:
NCT03820258
Status:
TERMINATED
Last Update Posted:
2020-10-23
First Post:
2019-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-19
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-14
First Submit QC Date:
None
Study First Post Date:
2019-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-08-13
Results First Submit QC Date:
None
Results First Post Date:
2020-08-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-28
Last Update Post Date:
2020-10-23
Last Update Post Date Type:
ACTUAL